CLDN12 and cervical cancer: Among the analyzed variables, the low CLDN12 expression (HR 2.615, p = 0.029), FIGO stage IIb/III/IV (HR 4.075, p = 0.002), and recurrence (HR 14.852, p < 0.001) were independent prognostic factors for the DSS of cervical cancer patients (Table 3).